RENOVARO INC.
Renovaro revolutionizes cancer and neurology care through early detection, drug discovery, and personalized treatments. AI-powered precision medicine.
Funding history
About RENOVARO INC.
How much funding has RENOVARO INC. raised?
RENOVARO INC. has raised $106.8M in total funding.
Where is RENOVARO INC. headquartered?
RENOVARO INC. is headquartered in Los Angeles, CA.
What does RENOVARO INC. do?
Renovaro revolutionizes cancer and neurology care through early detection, drug discovery, and personalized treatments. AI-powered precision medicine.
What problem does RENOVARO INC. solve?
Cancer and neurology patients need earlier detection and truly personalized treatment rather than one-size-fits-all therapies.
What's RENOVARO INC.'s solution?
Renovaro runs a full-stack Bio-AI platform spanning five pillars (Detect, Discover, Predict, De-risk, Personalize) for biomarker discovery, cancer diagnostics, and AI-driven drug discovery.
What makes RENOVARO INC. different?
It combines liquid biopsy and machine learning for earlier detection with its acquired GEDiCube technology, which has identified over 10,000 cancer-specific biomarkers across 13 cancer types, plus experimental CRISPR models for genetic-context-specific therapy evaluation.
What makes RENOVARO INC. notable?
Its co-founder and largest shareholder, Serhat Gumrukcu, was convicted and sentenced to life in prison for a murder-for-hire and wire-fraud scheme; the Nasdaq-listed company (RENB) renamed itself Lunai Bioworks in 2025 after Hindenburg Research called it a 'worthless AI shell game.'
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.